Evaluation In-Hospital Opioid Usage for Minimally Invasive Repair of Pelvic Organ Prolapse
International Urogynecology Journal · 2025
DOI: 10.1007/s00192-025-06478-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Urogynecology Journal, 2025. Verfasst von Murat Yavuz Koparal und 3 weiteren Autor:innen. Beteiligte Einrichtung: Urology Institute, University Hospitals Cleveland Medical Center, 11100 Euclid Ave, Cleveland, OH, 44106, USA. drmykoparal@gmail.com. Hauptthemen laut MEDLINE: Pelvic Organ Prolapse, Analgesics, Opioid, Postoperative Pain, Minimally Invasive Surgical Procedures. Die Arbeit nennt 31 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION AND HYPOTHESIS: To evaluate in-hospital analgesic use patterns for pelvic organ prolapse (POP) repair and identify predictors of higher opioid prescribing using a large, national patient administrative database. METHODS: This retrospective cohort study used a large, national administrative database (2010-2022) to identify women undergoing vaginal non-apical (NAR), vaginal apical (VAR), laparoscopic apical (LAR), or robotic apical (RAR) repairs. Opioid doses were converted to morphine milligram equivalents (MME). The primary outcome was total opioid, acetaminophen, and nonsteroidal anti-inflammatory drugs (NSAID) use. Secondary outcomes included differences in analgesic doses by surgical approach, predictors of higher POD-0 opioid use, postoperative 30-day readmission/emergency room (ER) visit rate, and the relationship between opioid use and 30-day readmission/ER visits. RESULTS: Among 102,329 procedures, median POD-0 opioid dose was lowest in NAR (77.5 MME) (p 90 MME on POD-0 was linked to higher 30-day readmission/ER visit rates (8.3% vs 5.6%; p < 0.001, respectively). CONCLUSIONS: Apical repair techniques did not show significant differences in predicting higher opioid use. Concurrent hysterectomy was the strongest predictor of higher opioid use. Higher opioid doses on POD-0 were associated with increased 30-day readmission/ER rates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Urology Institute, University Hospitals Cleveland Medical Center, 11100 Euclid Ave, Cleveland, OH, 44106, USA. drmykoparal@gmail.com.
- Case Western Reserve University, Cleveland, OH, USA. drmykoparal@gmail.com.
- Department of Urology, Gazi University, Ankara, Türkiye. drmykoparal@gmail.com.
- Urology Institute, University Hospitals Cleveland Medical Center, 11100 Euclid Ave, Cleveland, OH, 44106, USA.
- Case Western Reserve University, Cleveland, OH, USA.
ORCID-Profile: Murat Yavuz Koparal
Zitieren
APA
Koparal, M. Y., Rhodes, S., Sheyn, D., & Hijaz, A. (2025). Evaluation In-Hospital Opioid Usage for Minimally Invasive Repair of Pelvic Organ Prolapse. International Urogynecology Journal. https://doi.org/10.1007/s00192-025-06478-3
Vancouver
Koparal MY, Rhodes S, Sheyn D, Hijaz A. Evaluation In-Hospital Opioid Usage for Minimally Invasive Repair of Pelvic Organ Prolapse. International Urogynecology Journal. 2025. doi:10.1007/s00192-025-06478-3
BibTeX
@article{Koparal2025,
author = {Koparal, Murat Yavuz and Rhodes, Stephen and Sheyn, David and Hijaz, Adonis},
title = {Evaluation In-Hospital Opioid Usage for Minimally Invasive Repair of Pelvic Organ Prolapse},
journal = {International Urogynecology Journal},
year = {2025},
doi = {10.1007/s00192-025-06478-3}
}
EUVIMED